Sales in the first quarter of 2017 were up by 13% in total, hitting €2.16 billion compared to €1.91bn in the same period last year.
Net profit was up by a huge 75%, at €175 million, while adjusted EBITDA was up by 17% to €345m.
Sales in DSM’s Nutrition division were up by 12%, making up almost 1.4 bn of its 2.16 bn income in the quarter.
"We are pleased to report a very good start to the year, with continued positive momentum in all businesses as we execute on our mid-term strategic and financial ambitions,” said CEO and Chairman of the DSM Managing Board Feike Sijbesma. “Nutrition continued to deliver on its objectives with good growth from Animal and Human Nutrition.”
Both businesses achieved strong volume growth, well above the market.
Sijbesma added that both DSMs nutrition and materials business had achieved growth ‘well above the market’: “Notwithstanding the current global socio-economic volatility, we are confident that we will be able to deliver against our full-year objectives.”